4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-010721
Chief Executive Officer gave up 7,172 shares (to pay taxes)
- Chief Executive Officer acquired 24,474 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2024-03-31 | Option exercise | +24,474 | 173,302.8 | D: show line 1 in the form | ||
| Robinson Chandler Chief Executive Officer | 2024-03-31 | Shares withheld for taxes | −7,172 | $0.68 | $4,884 | 166,130.8 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robinson Chandler Chief Executive Officer | 2024-03-31 | Option exercise · Restricted Stock Units | −24,474 | 197,811 | D: show line 3 in the form |
Loading xslF345X05/rdgdoc.xml…